S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice

[1]  A. Toland,et al.  The role for oxidative stress in aberrant DNA methylation in Alzheimer's disease. , 2012, Current Alzheimer research.

[2]  S. Parmigiani,et al.  Vulnerability to chronic subordination stress-induced depression-like disorders in adult 129SvEv male mice , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  X. Estivill,et al.  DNA methylation in neurodegenerative disorders: a missing link between genome and environment? , 2011, Clinical genetics.

[4]  M. Tsolaki,et al.  Epigenetic mechanisms in Alzheimer's disease. , 2011, Current medicinal chemistry.

[5]  J. Issa,et al.  Epigenetics in cancer: what's the future? , 2011, Oncology.

[6]  A. Fuso,et al.  DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models. , 2011, The Journal of nutritional biochemistry.

[7]  Andrea Fuso,et al.  Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency , 2011, Neurobiology of Aging.

[8]  Mary Savage,et al.  Induction of Alzheimer’s‐like changes in brain of mice expressing mutant APP fed excess methionine , 2011, Journal of neurochemistry.

[9]  Ke-Qin Zhang,et al.  Homocysteine promotes proliferation and activation of microglia , 2010, Neurobiology of Aging.

[10]  H. Ryu,et al.  Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker? , 2010, BMB reports.

[11]  M. Gültekin,et al.  DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability , 2010, Cancer and Metastasis Reviews.

[12]  D. Wilcock.  The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease. , 2010, CNS & neurological disorders drug targets.

[13]  H. Steinbusch,et al.  Epigenetic regulation in the pathophysiology of Alzheimer's disease , 2010, Progress in Neurobiology.

[14]  Jia-min Zhuo,et al.  Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. , 2009, Current Alzheimer research.

[15]  A. Perna,et al.  Epigenetics in hyperhomocysteinemic states. A special focus on uremia. , 2009, Biochimica et biophysica acta.

[16]  J. Rogers,et al.  Epigenetic Differences in Cortical Neurons from a Pair of Monozygotic Twins Discordant for Alzheimer's Disease , 2009, PloS one.

[17]  D. Jacobs,et al.  Hypothesis: a Unifying Mechanism for Nutrition and Chemicals as Lifelong Modulators of DNA Hypomethylation , 2009, Environmental health perspectives.

[18]  Yu-hsuan Chen,et al.  S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. , 2009, Neurotoxicology.

[19]  Johannes Gräff,et al.  Epigenetic dysregulation in cognitive disorders , 2009, The European journal of neuroscience.

[20]  Kunlin Chen,et al.  The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. , 2009, Biochemical and biophysical research communications.

[21]  F. LaFerla,et al.  Treatment of Alzheimer's Disease with Anti-Homocysteic acid Antibody , 2008 .

[22]  H. Tanila,et al.  Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A , 2008, Neurobiology of Disease.

[23]  B. Shukitt-Hale,et al.  B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice , 2008, Proceedings of the National Academy of Sciences.

[24]  Sun-Chong Wang,et al.  Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease , 2008, PloS one.

[25]  J. Selhub.  Public Health Significance of Elevated Homocysteine , 2008, Food and nutrition bulletin.

[26]  F. D’Anselmi,et al.  B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice , 2008, Molecular and Cellular Neuroscience.

[27]  S. French,et al.  S‐adenosylmethionine prevents mallory denk body formation in drug‐primed mice by inhibiting the epigenetic memory , 2007, Hepatology.

[28]  J. Finkelstein,et al.  Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine , 2007, Clinical chemistry and laboratory medicine.

[29]  M. P. McDonald,et al.  Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet , 2007, Neurobiology of Aging.

[30]  A. McCaddon,et al.  Methylation and phosphorylation: a tangled relationship? , 2007, Clinical chemistry.

[31]  R. Diaz-Arrastia,et al.  Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation , 2007, The Journal of Neuroscience.

[32]  J. Mann,et al.  A controlled trial of homocysteine lowering and cognitive performance. , 2006, The New England journal of medicine.

[33]  M. Pappolla,et al.  Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels , 2006, Neurobiology of Disease.

[34]  J. Selhub,et al.  The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. , 2006, The Journal of nutrition.

[35]  N. Janel,et al.  Plasma homocysteine levels are not increased in murine models of Alzheimer's disease , 2005, Neuroscience Research.

[36]  M. Szyf.  Therapeutic implications of DNA methylation. , 2005, Future oncology.

[37]  Roland N. Emokpae,et al.  Folate deficiency inhibits proliferation of adult hippocampal progenitors , 2005, Neuroreport.

[38]  D. Katz,et al.  S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. , 2005, Clinical and investigative medicine. Medecine clinique et experimentale.

[39]  G. Higgins,et al.  Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice , 2005, Behavioural Brain Research.

[40]  F. D’Anselmi,et al.  S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production , 2005, Molecular and Cellular Neuroscience.

[41]  I. Rosenberg,et al.  The atherogenic effect of excess methionine intake , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Andrea Fuso,et al.  Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease? , 2003, FEBS letters.

[43]  R. Shore,et al.  Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus‐maze: importance and implications of behavioural baseline , 2002, Genes, brain, and behavior.

[44]  Sang-Woon Choi,et al.  In the cystathionine beta-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific. , 2002, The Journal of nutrition.

[45]  J. Stock,et al.  Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease , 2002, FEBS letters.

[46]  Simon Lovestone,et al.  Alzheimer's disease – do tauists and baptists finally shake hands? , 2002, Trends in Neurosciences.

[47]  B. Vellas,et al.  Nutritional factors and Alzheimer's disease. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[48]  S. Turner,et al.  Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695* , 2001, The Journal of Biological Chemistry.

[49]  K. Frick,et al.  Mice are not little rats: species differences in a one‐day water maze task , 2000, Neuroreport.

[50]  J. Miller,et al.  Homocysteine, Alzheimer's disease, and cognitive function. , 2000, Nutrition.

[51]  J. Finkelstein,et al.  The metabolism of homocysteine: pathways and regulation , 1998, European Journal of Pediatrics.

[52]  A. Fuso,et al.  B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A. , 2010, Journal of Alzheimer's disease : JAD.

[53]  A. Fuso,et al.  S-adenosylmethionine prevents oxidative stress and modulates glutathione metabolism in TgCRND8 mice fed a B-vitamin deficient diet. , 2010, Journal of Alzheimer's disease : JAD.

[54]  W. V. van Gool,et al.  Hyperhomocysteinemia and Alzheimer's disease: A systematic review. , 2009, Archives of gerontology and geriatrics.

[55]  F. D’Anselmi,et al.  gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. , 2007, Journal of Alzheimer's disease : JAD.

[56]  F. D’Anselmi,et al.  The effect of S-adenosylmethionine on CNS gene expression studied by cDNA microarray analysis. , 2006, Journal of Alzheimer's disease : JAD.

[57]  F. D’Anselmi,et al.  Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. , 2006, Journal of Alzheimer's disease : JAD.

[58]  M. Tettamanti,et al.  Homocysteine and B vitamins in mild cognitive impairment and dementia , 2005, Clinical chemistry and laboratory medicine.

[59]  N. Zawia,et al.  Environmental Risk Factors and the Developmental Basis for Alzheimer's Disease , 2005, Reviews in the neurosciences.

[60]  W. Herrmann,et al.  Hyperhomocysteinemia: a new risk factor for degenerative diseases. , 2002, Clinical laboratory.